4//SEC Filing
Sansone Christopher R. 4
Accession 0001014108-21-000201
CIK 0001337013other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 5:42 PM ET
Size
7.6 KB
Accession
0001014108-21-000201
Insider Transaction Report
Form 4
Sansone Christopher R.
Director
Transactions
- Sale
Common Stock
2021-11-22$17.73/sh−80,000$1,418,400→ 228,118 total(indirect: See)
Holdings
- 0
Common Stock
- 1,464,916(indirect: See)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
InfuSystem Holdings, Inc
CIK 0001337013
Entity typeother
Related Parties
1- filerCIK 0001519525
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 5:42 PM ET
- Size
- 7.6 KB